SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF EFFICACY AND SAFETY/TOLERABILITY OF 3RD AGENT ANTIRETROVIRAL TREATMENTS IN ANTIRETROVIRAL-NAÏVE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 POSITIVE PATIENTS, Trial ID 200116 | GSK